AL-LAD
Discover related
4 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
| PsychonautWiki | TripSit | Pharmacology | TiHKAL | ||
|---|---|---|---|---|---|
| Classification | |||||
| Class / category | — | — | ≈ | ||
| Also known as | AL-LADAladdin | allad | — | 6-NORLYSERGAMIDE, 6-ALLYL-N,N-DIETHYLN,N-DIETHYLNORLYSERGAMIDE, 6-ALLYLN-(6)-ALLYLNORLYSERGIC ACID, N,N-DIETHYLAMIDE9,10-DIDEHYDRO-6-ALLYL-N,N-DIETHYLERGOLINE-8b-CARBOXAMIDE | ≠ |
| Safety | |||||
| Addiction potential | not habit-forming | — | — | — | |
| Toxicity | toxic dose is unknownextremely low toxicity | — | — | — | |
| Dangerous interactions | — | — | — | ||
| Unsafe interactions | — | — | — | ||
| Dose · Oral | |||||
| Threshold | 20 µg | — | — | — | |
| Light | 50–100 µg | 40–75 µg | — | — | ≠ |
| Common | 100–225 µg | 75–175 µg | — | 80–160 µg | ≠ |
| Strong | 225–350 µg | 175–250 µg | — | — | ≠ |
| Heavy | 350 µg+ | 250 µg+ | — | — | ≠ |
| Duration | |||||
| Onset | 20–60 minutes | 45–120 minutes | — | — | ≠ |
| Total | 7–10 hours | 4–6 hours | — | 6–8 hours | ≠ |
| After-effects | 2–18 hours | 1–24 hours | — | — | ≠ |
| Pharmacology | |||||
Dose at a glance
Each database's primary-route ladder on one shared scale — see where ranges line up or shift.
Duration at a glance
Total duration on one shared scale.
TripSit summary
AL-LAD is a hallucinogenic drug, lysergamide and an analogue of LSD. It is reported as having some subtle experiential differences to LSD (such as increased visuals), and also appears to be slightly shorter lasting. AL-LAD doses are similar to those of LSD, depending on purity. Its availability on the Internet since 2013 has lead to strong popularity among the drug community.
TiHKAL summary
The commentary here concerns the family of N,N-dialkyl tryptamine relatives and the general finding that activity tends to fade as the nitrogen-bound carbon chains grow longer, with the longest examples inactive or untested. It reads mainly as a discussion of naming and homologue trends rather than a description of the named drug's own effects.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.